| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $129.0M | +0.1% | -6.0% |
| Cost of Revenue | $35.3M | +7.3% | +2.8% |
| R&D Expense | $13.8M | -3.7% | -7.7% |
| SG&A Expense | $21.2M | +8.8% | -2.4% |
| Operating Income | -$34.3M | -190.2% | -274.1% |
| Interest Expense | $14.8M | -1.4% | -6.9% |
| Pre-tax Income | -$50.1M | -106.9% | -96.7% |
| Income Tax | -$8.8M | -2010.1% | -373.3% |
| Net Income | -$41.3M | -73.5% | -74.9% |
| EPS (Basic) | -$4.74 | -70.5% | -65.7% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $74.6M | -25.8% | -23.8% |
| Accounts Receivable | $103.9M | +7.4% | +1.4% |
| Current Assets | $230.7M | -8.8% | -11.3% |
| Total Assets | $897.6M | -7.4% | -14.8% |
| Current Liabilities | $273.0M | -8.0% | -7.1% |
| Long-term Debt | $570.2M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.4M | — | — |
| Capital Expenditures | $1.6M | — | — |
| Investing Cash Flow | -$14.6M | — | — |
| Financing Cash Flow | -$8.0M | — | — |
| Free Cash Flow | -$7.0M | — | — |
| -0.7% |
| Stockholders' Equity | $4.0M | -90.6% | -96.7% |